Literature DB >> 8249672

Transient "cerebellar" mutism in lesions of the mesencephalic-cerebellar region.

R D'Avanzo1, A Scuotto, M Natale, P Scotto, F A Cioffi.   

Abstract

Four patients aged from 20 to 48 years with transient mutism are presented: 3 patients underwent surgery for midline tumours of the mesencephalic-cerebellar region (medulloblastoma in two cases and pinealoblastoma in one), at times attached to one or both lateral recesses of the IV ventricle. One patient was hospitalized and treated for brain-stem ischemia. All patients developed mutism 48 to 72 hours after surgery; in the patient with brain-stem softening mutism appeared 72 hours after admission. All the patients had unimpaired consciousness and no deficits of lower cranial nerves. Speech, always normal in the first hours after surgery, was regained after a period of 6-16 weeks. Various hypotheses for this speech disorder are analyzed.

Entities:  

Mesh:

Year:  1993        PMID: 8249672

Source DB:  PubMed          Journal:  Acta Neurol (Napoli)        ISSN: 0001-6276


  4 in total

1.  Cerebellar mutism: definitions, classification and grading of symptoms.

Authors:  Thora Gudrunardottir; Astrid Sehested; Marianne Juhler; Jacques Grill; Kjeld Schmiegelow
Journal:  Childs Nerv Syst       Date:  2011-07-06       Impact factor: 1.475

2.  Cerebellar Mutism Syndrome After Posterior Fossa Surgery: A Report of Two Cases of Pilocytic Astrocytoma.

Authors:  Hasan Burak Gündüz; Mustafa İlker Kuntay Yassa; Ali Ender Ofluoğlu; Lütfü Postalci; Erhan Emel
Journal:  Noro Psikiyatr Ars       Date:  2013-12-01       Impact factor: 1.339

Review 3.  Cerebellar mutism: review of the literature.

Authors:  Thora Gudrunardottir; Astrid Sehested; Marianne Juhler; Kjeld Schmiegelow
Journal:  Childs Nerv Syst       Date:  2011-03       Impact factor: 1.475

Review 4.  Postoperative cerebellar mutism in adult patients with Lhermitte-Duclos disease.

Authors:  Ali Afshar-Oromieh; Heinz Linhart; Dino Podlesek; Wiebke Schrempf; Gabriele Schackert; Dietmar Krex
Journal:  Neurosurg Rev       Date:  2010-07-29       Impact factor: 3.042

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.